I apply the same grit and passion to solving clients’ toughest problems as they bring to their innovative businesses.
Patrick Connolly works closely with innovators and their investors, from formation through exit. He has spent his entire career counseling on issues like company formation and inter-founder matters, venture capital financing, commercial transactions and mergers and acquisitions. He has been named a Top Lawyer by Boston Magazine by his peers, and a Go-To Lawyer by Massachusetts Lawyers Weekly for his work on behalf of his transactional clients.
Patrick counsels emerging companies in several industry verticals, including biotechnology, digital health, cannabis, software, e-commerce, edtech and cleantech. He has counseled on hundreds of venture financings and strategic transactions throughout his career. As a result, Patrick brings a deep understanding of both the unique legal challenges and marketplace realities facing clients within the industries he serves.
Patrick serves as Co-Chair of the firm's Emerging Company and Venture Capital group, and actively supports ecosystem efforts organized and founded by groups like MassChallenge, MIT and Harvard University.
Boston College Law School, J.D., magna cum laude, 2009
Dartmouth College, B.A., 2001
Bar and Court Admissions
BAR ADMISSIONS
Massachusetts
Experience
LIFE SCIENCES AND DIGTIAL HEALTH
Jana Care, developer of a mobile diagnostic platform designed for chronic disease management, in connection with its $14.4 million Series B financing
Genialis in a $13 million Series A financing led by Debiopharm Innovatoin Fund and Taiwania Capital to expand its proprietary ResponderID machine learning platform for clinical and translational research
Alloy Therapeutics in several matters, including:
$42 million Series D financing round led by its existing investors 8VC and Mubadala Capital
Series A Preferred Stock Financing of Vernal Biosciences, a manufacturer of high purity mRNA for research and clinical use
its $75.0 million Series C Financing led by 8VC, Presight Capital and Peter Thiel
with the formation of Broadwing Bio LLC, a joint venture with Maze Therapeutics, Inc., to develop targeted antibody therapies for the treatment of ophthalmic diseases
H.I.G. BioHealth Partners and Accelmed Partners as new investors and co-leads in the $52 million upsized Series B financing of digital therapeutics company Click Therapeutics, Inc. (“Click”)
Alcyone Therapeutics in relation to a $23.0 million financing led by funds affiliated with RTW Investments, LP., to support its pioneering development of next-generation precision central nervous system therapies
BostonGene, a developer of biomedical software for advanced patient analysis and personalized therapy, in connection with its $150 million Series B financing, which resulted in the company gaining “unicorn” status
Soriant Healthcare, a market leader in partnering with hospitals and health systems to accelerate performance and reduce expenditures in all support services, in its sale to Vizient, the nation's largest member-driven health care performance improvement company
Morphic Therapeutic, a high-growth biotech company, in multiple transactions, including:
$80 million Series B financing
$51.5 million Series A financing
Arsanis, an biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens in its closing of $45.5 million Series D financing
Immunetics, a biotechnology company focused on the diagnosis of lyme diseases, in its sale to Oxford Immunotec Global PLC
TECHNOLOGY
Cruisebound, an online travel site in its $10 million Series A funding, led by former Booking Holdings chairman and Priceline CEO Jeff Boyd and PAR Capital Ventures, with participation from several others
Ellevation, a mission-driven software company focused exclusively on English Learners and the educators who serve them, in its sale to Curriculum Associates
Zapata AI, a high-growth generative AI company in multiple financing rounds, including:
its $38 million Series B financing, led by Comcast Ventures, Pitango and Prelude Ventures
$21 million Series A financing
Brammo, Inc. a producer of electric vehicle technologies in its sale to global power leader Cummins
Curriculum Associates, a k-12 edtech company, in its acquisition of Motion Math
String Automotive, an analytics company focused on the auto industry in its acquisition by Experian Automotive, a division of Experian Plc
WHI Solutions, an e-commerce business focused on the auto industry in its sale to eBay Inc.
OnShape in its $25 million Series B financing
Honors & Involvement
HONORS
"Go To Lawyer - Business Transactions," Massachusetts Lawyers Weekly, 2024
“Top Lawyer – Corporate Law,” Boston Magazine, 2021
INVOLVEMENT
American Bar Association, Member
Massachusetts Bar Association, Member
Boston Bar Association, Member
The Foley Hoag Foundation, Grant Proposal Reviewer
Moderator, "State of Medtech Investments," BIOMEDevice and MassMedic Master Class Startup Series (September 2022)
Moderator, "MassChallenge and Foley Hoag Present Digital Health: Notes from the Field," MassChallenge (June 2022)
Presenter, "Negotiating a Term Sheet: Creating a Win-Win Situation for All," MassChallenge (April 2022)
Presenter, "Legal Workshop: Company Formation," Lawyers for Civil Rights: Boston and Hyde Park Main Streets, and West Roxbury Main Streets (March 2022)
Presenter, "How 2 Understand the Legal Basics for Startups," Babson Entrepreneurs Group (April 2020)
Presenter, "Issues to Address When Dealing with Strategic/Corporate Venture Capitalists," Boston Bar Association: Venture Capital & Private Equity Conference (April 2019)
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
